Global POC Urinalysis Market 2018-2022
About this market
With the increase in UTI’s and nephropathic disorders, the demand for the diagnostic systems, especially POC has grown immensely over the last few years. The POC is the fastest growing segment of the diagnostic systems. Several companies in this market develop and distribute products in partnership, which ultimately helps to cover a larger geographical area and obtain higher ROI as the product is co-developed and marketed. For instance, Sysmex, a diversified player, partnered with Siemens Healthcare to provide a fully integrated system called as CLINITEK AIPNi. Therefore, the growing partnerships within the industry will boost the growth of the POC urinalysis market. Technavio ‘s analysts predict this market to grow at a CAGR of over 3 % by 2022.
Rising prevalence of nephropathic disorders and UTI’s
Over the past few years, the lifestyle diseases like hypertension, diabetes, and obesity has significantly increased, adversely impacting excretion system which includes skin, urinary tract, bladder, and kidneys. As it impacts the content, appearance and concentration of urine, it leads to various nephropathic disorders. Whereas, UTI is the most common non-intestinal infection worldwide. These factors are poised to contribute to the growth of the POC urinalysis market.
Low efficacy of POC devices
There are several challenges with respect to POC, mainly related to quality assurance. To ensure the accuracy of the test result, the outcome of the result is often compared with the traditional pathology. Many rapid diagnostic kits have failed to provide accurate results, especially during emergencies. The uncertainty of result is hampering the adoption of POC diagnostic devices.
For the detailed list of factors that will drive and challenge the growth of the POC Urinalysis market during 2018-2022, view our report.
The global POC urinalysis market appears to be fragmented owing to the presence of several POC urinalysis device manufacturers who offer a range of POC devices such as urinalysis test consumables and urinalysis test systems. Some of the factors impacting the growth of the market include the rising prevalence of nephropathic disorders and UTIs, and the growing partnerships among companies. Abbott BD, Danaher, F. Hoffmann-La Roche, and Siemens Healthcare are some of the top companies in the market.
‘With the presence of a considerable number of companies, this market appears to be fragmented. This market research report will help clients identify new growth opportunities. Many companies in the POC urinalysis market are focusing on selling their products in partnership that helps to cover a larger geographical area.’